96. Dissection of the expressed actionable fusions' repertoire in solid tumors in a clinical setting across 14 cancer types
Large studies based on DNA-based NGS testing alongside clinical trials have established the prevalence of clinically actionable gene fusions such as NTRK1/2/3. However, much less is known about the broader repertoire and prevalence of bonafide expressed gene fusions.
Source: Cancer Genetics and Cytogenetics - Category: Genetics & Stem Cells Authors: Fernando Lopez-Diaz, Rachel Schell, Chaugiang Duong, Steven Rivera, Vincent Funari Source Type: research